7 recruiting, 1 not yet recruiting. 8 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Recruiting 7, Not yet recruiting 1 |
| Phase 3 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Prostate CA: new trials by email Literature Review of Prostate CA trials Research Report on Prostate CA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer Fezolinetant - Prostate CA, Androgen Deprivation Therapy | Phase 2 | Recruiting | University of Vermont | 32 | 2025-12-18 | 2026-02-05 |
| Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer Stereotactic Body Radiation Therapy (SBRT) - Prostate CA | Phase 2 | Recruiting | British Columbia Cancer Agency | 100 | 2025-09-04 | 2026-06-24 |
| Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer 68Ga-PSMA-CYC, CYC - Prostate CA | Phase 1 / Phase 2 | Recruiting | First Affiliated Hospital of Fujian Medical University | 40 | 2025-05-15 | 2025-07-09 |
| Ultralow Dose PET Imaging for PSMA Expression Piflufolastat F18 - Healthy Volunteer, Prostate CA | Phase 2 | Recruiting | Akiva Mintz | 200 | 2025-05-12 | 2025-06-04 |
| Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer Homoharringtonine combined with androgen deprivation therapy, Placebo combined with androgen deprivation treatment group, radical prostatectomy - Prostate CA | Phase 2 | Recruiting | baotai Liang | 96 | 2025-03-19 | 2025-09-08 |
| Clinical Study of Geranium Wilfordii Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer Geranium wilfordii combined with androgen deprivation treatment, Androgen deprivation treatment, radical prostatectomy - Prostate CA | Phase 2 / Phase 3 | Not yet recruiting | baotai Liang | 95 | 2025-03-10 | 2025-03-06 |
| Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer Fasudil hydrochloride and PD1 inhibitor combined with androgen deprivation therapy, Placebo combined with androgen deprivation therapy, radical prostatectomy - Prostate CA | Phase 2 / Phase 3 | Recruiting | baotai Liang | 83 | 2025-02-16 | 2025-11-18 |
| FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer FK-PC101, Standard of Care (SOC) - Prostate Cancer (Adenocarcinoma), Prostate CA | Phase 2 | Recruiting | Cellvax Therapeutics Inc | 100 | 2024-10-14 | 2024-10-21 |
Prostatic Neoplasms (4) · Adenocarcinoma (1) · Hot Flashes (1)
Genital Diseases (4) · Genital Diseases, Male (4) · Genital Neoplasms, Male (4) · Male Urogenital Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Prostatic Diseases (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Carcinoma (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Androgen Antagonists (2) · 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (1) · Blood Specimen Collection (1) · Magnetic Resonance Spectroscopy (1) · Radiosurgery (1) · Standard of Care (1) · Surgical Procedures, Operative (1) · fasudil (1) · fezolinetant (1)
baotai Liang (3) · Akiva Mintz (1) · British Columbia Cancer Agency (1) · Cellvax Therapeutics Inc (1) · First Affiliated Hospital of Fujian Medical University (1) · University of Vermont (1)
China (3) · United States (3) · Canada (1)
Abraham Alexander (1) · Fernando Kreutz, MD PhD (1) · Weibing Miao, MD (1) · Winkle Kwan (1)